In Special Recognition of the work of The Stand Up To Cancer-Lustgarten Foundation Pancreatic Dream Team and in honor of Pancreatic Cancer Awareness Month
"I am thrilled to be partnering with
Myeloid cells play a key role in modulating activities fundamental to cancer development and are known to have both tumor promoting and anti-tumor functions. As myeloid cells are affected by and can have an impact on many types of cancer therapy, they are broadly applicable within immuno-oncology research. A heightened awareness of the importance of the mechanisms of immunotherapy resistance has brought the myeloid immune response into focus as a key modulator of the adaptive immune response.
The Myeloid Innate Immunity panel includes approximately 700 genes representing all major categories of myeloid cells, enabling quantitative evaluation of heterogeneous myeloid cell populations based on recruitment, differentiation, maturation status, and functional activities. The panels are optimized to work across a range of sample types including fresh frozen tissues, formalin-fixed paraffin-embedded (FFPE) samples, peripheral blood mononuclear cells and cell lysates.
"It has been a pleasure to collaborate with
This is the latest in a series of research partnerships
Results from NanoString's previously announced collaborations with
- Title: Beyond PD-L1 IHC: A Gene Expression Based Test in development for anti-PD-1 response on the nCounter® Dx Analysis System
- Speaker: Dr.
- Title: The increasing clinical relevance of predictive biomarkers in cancer immunotherapy: can we afford to move forward
About the Stand Up To Cancer Initiative
Vice President, Communications
For more information, please visit www.nanostring.com.
The NanoString Technologies logo, NanoString, NanoString Technologies, nCounter, 3D Biology, and Prosigna are registered trademarks of NanoString Technologies, Inc.
Vice President, Investor Relations and Corporate Communications
News Provided by Acquire Media